Published in Invest Ophthalmol Vis Sci on October 01, 1989
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet (2005) 4.17
Tetraspanins. Cell Mol Life Sci (2001) 3.33
Severely reduced female fertility in CD9-deficient mice. Science (2000) 2.80
Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella. J Infect Dis (1975) 2.66
Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) (1975) 2.61
Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29
West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis (2001) 2.15
Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein. J Biol Chem (1999) 1.97
Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery (1995) 1.80
Insensitivity of peptidoglycan biosynthetic reactions to beta-lactam antibiotics in a clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 1.78
The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem (2001) 1.74
Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J (1999) 1.72
Disc space infection and vertebral osteomyelitis as a complication of percutaneous lateral discectomy. Clin Orthop Relat Res (1987) 1.62
Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob Chemother (2004) 1.60
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother (1988) 1.55
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother (2003) 1.55
Prevalence of HIV antibodies in transsexual and female prostitutes. Am J Public Health (1992) 1.47
Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects. Antimicrob Agents Chemother (1989) 1.41
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
Human live anthrax vaccine in the former USSR. Vaccine (1994) 1.40
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. Infection (2007) 1.39
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer (1990) 1.31
CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J Biol Chem (1998) 1.26
CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. Eur J Immunol (2000) 1.25
Tetraspanins and malignancy. Expert Rev Mol Med (2001) 1.23
Sequence and expression of seven new tetraspans. Biochim Biophys Acta (2000) 1.19
Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med (1975) 1.16
Tissue penetration of amphotericin B in Candida endocarditis. Chest (1974) 1.16
The untold story of HUT78. Science (1990) 1.14
Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother (1994) 1.14
Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. N Engl J Med (1974) 1.13
Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol (1997) 1.12
Formalin treatment of radiation-induced hemorrhagic proctitis. Am J Gastroenterol (1986) 1.09
Cell surface hydrophobicity of pigmented and nonpigmented clinical Serratia marcescens strains. Infect Immun (1986) 1.08
Regional analysis of functions and demographics of health information managers. J AHIMA (1996) 1.06
CD9 and megakaryocyte differentiation. Blood (2001) 1.06
The first adult case with 4-hydroxybutyric aciduria. J Inherit Metab Dis (1990) 1.04
Adherence properties of Staphylococcus aureus under static and flow conditions: roles of agr and sar loci, platelets, and plasma ligands. Infect Immun (2001) 1.04
Corynebacterium diphtheriae endocarditis. Am J Med Sci (1976) 1.03
The in-vitro anti-rickettsial activity of macrolides. J Antimicrob Chemother (1996) 1.03
In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. J Antimicrob Chemother (2003) 1.02
Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob Agents Chemother (1990) 1.01
Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel. Eur J Clin Microbiol Infect Dis (2006) 1.00
The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci (1991) 0.99
Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon. Exp Hematol (1991) 0.99
Quiescent Q fever endocarditis exacerbated by cardiac surgery and corticosteroid therapy. Arch Intern Med (1988) 0.99
Surgical excision of meningiomas involving the clivus: preoperative and intraoperative features as predictors of postoperative functional deterioration. J Neurosurg (1994) 0.98
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin. Antimicrob Agents Chemother (1992) 0.98
Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Antimicrob Agents Chemother (1990) 0.97
Hematemesis caused by jejunogastric intussusception. Endoscopy (1986) 0.97
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. Scand J Infect Dis (1998) 0.96
Quinolones for the treatment of brucellosis. J Antimicrob Chemother (1992) 0.96
[Retrospective diagnosis of anthrax by intradermal reaction]. Med Trop (Mars) (1993) 0.96
Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers. Antimicrob Agents Chemother (1989) 0.96
Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect (2004) 0.95
Prediction of creatinine clearance from serum creatinine concentration based on lean body mass. Clin Pharmacol Ther (1981) 0.95
Antigen-antibody complexes in or on eosinophils in nasal secretions. Int Arch Allergy Appl Immunol (1975) 0.95
Estimating the effects of nosocomial infections on the length of hospitalization. J Infect Dis (1982) 0.95
Bacterial meningitis. A follow-up study of 115 children. Isr J Med Sci (1982) 0.95
Drug interactions of ciprofloxacin with other non-antibiotic agents. Am J Med (1987) 0.94
The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother (1982) 0.94
In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines. J Pharmacol Exp Ther (1989) 0.94
Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants. Antimicrob Agents Chemother (1996) 0.94
The IL-2 receptor present on human embryonic fibroblasts is functional in the absence of P64/IL-2R gamma chain. Int Immunol (1993) 0.94
Human melanoma cells express a functional interleukin-2 receptor. Int J Cancer (1993) 0.93
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model. J Antimicrob Chemother (1989) 0.93
The effect of ischemia of the dog's colon on transmural migration of bacteria and endotoxin. J Surg Res (1983) 0.93
Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis (1996) 0.93
Intestinal elimination of ciprofloxacin in rabbits. Antimicrob Agents Chemother (1994) 0.92
Failure of influenza vaccination in the aged. J Med Virol (1988) 0.92
The influence of endotoxin-induced pyrexia on the pharmacokinetics of gentamicin in the rabbit. J Pharmacol Exp Ther (1981) 0.92
A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemother (2005) 0.91
Antibacterial activity of the pancreatic fluid. Gastroenterology (1985) 0.91
The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in in-vitro systems. J Antimicrob Chemother (1994) 0.91
Murine typhus and spotted fever in Israel in the eighties: retrospective analysis. Infection (1989) 0.91
Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol (2002) 0.89
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. Clin Neuropharmacol (1996) 0.89
Brucellosis. Int J Antimicrob Agents (1995) 0.89
Determination of midazolam and its alpha-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography. Ther Drug Monit (1993) 0.89
Gas and air embolization during hysteroscopic electrosurgical vaporization: comparison of gas generation using bipolar and monopolar electrodes in an experimental model. J Am Assoc Gynecol Laparosc (2001) 0.89
Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol (1999) 0.89
Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Curr Med Res Opin (1989) 0.88
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase. J Pharmacol Exp Ther (2002) 0.88
Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. Int J Antimicrob Agents (1992) 0.88
Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother (1998) 0.87
The effect of dimethyl sulfoxide on tissue distribution of gentamicin. Experientia (1980) 0.87
Increase of the intestinal absorption of gentamicin and amikacin by a nonionic surfactant. Antimicrob Agents Chemother (1981) 0.87
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrob Agents Chemother (1991) 0.87
Regional expression and androgen regulation of carbonic anhydrase IV and II in the adult rat epididymis. Biol Reprod (1999) 0.86
Motor-car accidents during pregnancy. Med J Aust (1977) 0.86
Endogenous endophthalmitis due to Salmonella typhimurium. Ann Ophthalmol (1983) 0.86
Expression of the interleukin-2 receptor on human fibroblasts and its biological significance. Int Immunol (1992) 0.86
Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever. Isr Med Assoc J (2000) 0.86
Human melanoma cell line M14 secretes a functional interleukin 2. Oncogene (1993) 0.86
Letter: Foley catheter perforation of the urinary bladder. JAMA (1976) 0.85
Evidence for a passive diffusion mechanism for sparfloxacin uptake at the brush-border membrane of the human intestinal cell-line Caco-2. J Pharm Sci (1997) 0.85
A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion. Thromb Haemost (2001) 0.85
Relapse of rickettsial Mediterranean spotted fever and murine typhus after treatment with chloramphenicol. J Infect (1989) 0.85
The penetration of gentamicin into the vitreous humor in man. Invest Ophthalmol Vis Sci (1983) 0.85